News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,462 Results
Type
Article (9083)
Company Profile (142)
Press Release (481132)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167975)
Career Advice (366)
Deals (25894)
Drug Delivery (10)
Drug Development (53791)
Employer Resources (17)
FDA (9982)
Job Trends (8765)
News (240655)
Policy (18287)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (568)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (101)
Alliances (33504)
ALS (104)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (268)
Approvals (10592)
Artificial intelligence (323)
ASCO (164)
Autoimmune disease (208)
Automation (28)
Bankruptcy (262)
Best Places to Work (7114)
BIO (38)
BIOSECURE Act (1)
Biosimilars (110)
BioSpace Insights (19)
Biotechnology (90)
Bladder cancer (140)
Brain cancer (32)
Breast cancer (520)
Cancer (3718)
Cardiovascular disease (221)
Career advice (302)
Career pathing (3)
CAR-T (176)
CDC (1)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (37)
Clinical research (48505)
Collaboration (1261)
Commercialization (3)
Compensation (1444)
Complete response letters (34)
COVID-19 (949)
CRISPR (66)
C-suite (740)
Cystic fibrosis (88)
Data (5720)
Denatured (4)
Depression (102)
Dermatology (64)
Diabetes (346)
Diagnostics (4233)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (167)
Earnings (73866)
Editorial (4)
Employer branding (3)
Employer resources (16)
Events (88211)
Executive appointments (708)
FDA (12627)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (933)
Gene editing (130)
Generative AI (10)
Gene therapy (321)
GLP-1 (302)
Government (1070)
Grass and pollen (2)
Guidances (284)
Healthcare (9555)
Hematology (97)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (100)
Immuno-oncology (59)
Indications (157)
Infectious disease (1147)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (89)
Intellectual property (257)
Interviews (48)
IPO (12436)
IRA (2)
Job creations (2007)
Job search strategy (281)
JPM (3)
Kidney cancer (16)
Labor market (3)
Layoffs (63)
Leadership (3)
Legal (5229)
Licensing (7)
Liver cancer (45)
Longevity (15)
Lung cancer (518)
Lymphoma (249)
Machine learning (27)
Management (4)
Manufacturing (545)
Marketing (8)
MASH (118)
Medical device (8720)
Medtech (8861)
Mergers & acquisitions (14494)
Metabolic disorders (711)
mRNA (60)
Multiple sclerosis (109)
NASH (4)
Neurodegenerative disease (221)
Neuropsychiatric disorders (39)
Neuroscience (1831)
NextGen: Class of 2026 (3230)
Non-profit (947)
Obesity (227)
Opinion (16)
Ovarian cancer (167)
Pain (174)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (13)
Patents (476)
Patient recruitment (516)
Peanut (31)
People (41516)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15655)
Phase 2 (21607)
Phase 3 (14674)
Pipeline (7264)
Policy (22)
Postmarket research (1616)
Preclinical (6659)
Press Release (35)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (197)
Rare diseases (579)
Real estate (3114)
Recruiting (7)
Regulatory (15076)
Reports (20)
Research institute (658)
Resumes & cover letters (57)
Rett syndrome (41)
RNA editing (6)
RSV (50)
Schizophrenia (99)
Series A (154)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Special edition (1)
Spinal muscular atrophy (95)
Sponsored (6)
Startups (2062)
State (1)
Stomach cancer (3)
Supply chain (54)
Vaccines (383)
Venture capital (21)
Weight loss (77)
Women's health (79)
Date
Today (93)
Last 7 days (544)
Last 30 days (1628)
Last 365 days (19411)
2026 (12060)
2025 (19521)
2024 (23255)
2023 (26861)
2022 (35022)
2021 (37748)
2020 (34018)
2019 (23775)
2018 (17841)
2017 (19070)
2016 (18221)
2015 (24513)
2014 (21855)
2013 (18327)
2012 (20437)
2011 (20629)
2010 (20496)
Location
Africa (251)
Alabama (72)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (18358)
Australia (2255)
California (11902)
Canada (3164)
China (545)
Colorado (479)
Connecticut (408)
Delaware (218)
Europe (25922)
Florida (1776)
Georgia (381)
Hawaii (4)
Idaho (47)
Illinois (705)
India (48)
Indiana (320)
Iowa (14)
Japan (400)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (27)
Maryland (1214)
Massachusetts (7875)
Michigan (306)
Minnesota (562)
Mississippi (4)
Missouri (89)
Montana (20)
Nebraska (11)
Nevada (118)
New Hampshire (60)
New Jersey (2667)
New Mexico (12)
New York (2811)
North Carolina (1285)
North Dakota (4)
Northern California (5963)
Ohio (277)
Oklahoma (14)
Oregon (17)
Pennsylvania (2266)
Puerto Rico (20)
Rhode Island (31)
South America (426)
South Carolina (77)
South Dakota (1)
Southern California (4933)
Tennessee (125)
Texas (1950)
United States (38895)
Utah (358)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (921)
West Virginia (1)
Wisconsin (76)
490,462 Results for "cold genesys inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RECKITT ANNOUNCES U.S. FDA APPROVAL OF MUCINEX® 12HR COLD & FEVER MULTI-SYMPTOM, THE FIRST OTC INNOVATION IN THE COLD & FLU CATEGORY IN 14 YEARS
August 5, 2026
·
5 min read
Press Releases
Alpha Genesis Adds Rodent Studies, Creating an Integrated Rodent-to-Primate Preclinical Platform
July 8, 2026
·
3 min read
Press Releases
Peli BioThermal Partners with PAXAFE to Redefine Pharmaceutical Cold Chain Intelligence
July 28, 2026
·
6 min read
Press Releases
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
May 20, 2026
·
5 min read
Press Releases
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
June 10, 2026
·
3 min read
Press Releases
Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan
July 29, 2026
·
3 min read
Press Releases
X-Therma Launches XT-NoVo® & TimeSeal® Platform: Shattering Cold Chain Barriers for On-Demand Regenerative Medicine
June 10, 2026
·
3 min read
Press Releases
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors
July 30, 2026
·
6 min read
Press Releases
Genesys Spine Announces Positive Prospective Study Results for SIros® Lateral SI Joint Fusion System
February 8, 2026
·
2 min read
Press Releases
Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs
April 1, 2026
·
2 min read
1 of 49,047
Next
